Gram-negative bacterial infections
MONDO:0021678Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.
Also known as: bacterial infection, gram-negative, bacterial infections, gram negative, bacterial infections, gram-negative, bacterial infections, gramme negative, gram negative bacterial infections, gram-negative bacterial infection, gramme negative bacterial infections, infection, gram-negative bacterial
293 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Could a simple pill replace the shot for syphilis?
⭐️ CURE ⭐️ CompletedThis study tested whether a 14-day course of doxycycline pills works as well as the standard penicillin shot for curing early syphilis. About 200 adults with early-stage syphilis took part. The goal is to offer a reliable oral option, especially when penicillin is in short supply…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 07:58 UTC
-
Could a Lower-Dose polio vaccine help eradicate the disease?
⭐️ VACCINE ⭐️ CompletedThis study tests a hexavalent vaccine that protects against six diseases, including polio, but uses a lower dose of the inactivated polio vaccine (IPV). The goal is to see if this reduced-dose version works as well as the standard full-dose vaccine in infants. Around 1,500 health…
Phase: PHASE3 • Sponsor: Serum Institute of India Pvt. Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 03, 2026 00:00 UTC
-
Thousands monitored: is the whooping cough vaccine safe in real life?
⭐️ VACCINE ⭐️ CompletedThis completed study tracked over 10,000 people in Thailand who received the Boostagen® vaccine, which protects against tetanus, diphtheria, and whooping cough. Healthcare workers reported any side effects to see how safe the vaccine is in everyday use. The study also looked at p…
Sponsor: BioNet-Asia Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:09 UTC
-
Nasal whooping cough vaccine gets a boost: higher dose tested in adults
⭐️ VACCINE ⭐️ CompletedThis study tested a higher dose of a new nasal vaccine (BPZE1) for whooping cough in 54 healthy adults aged 18-32. The goal was to see if the higher dose is safe and helps the vaccine take hold in the nose to trigger protection. Researchers monitored side effects and checked if t…
Phase: PHASE1 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:08 UTC
-
Hexaxim vaccine safety confirmed in 713 infants
⭐️ VACCINE ⭐️ CompletedThis completed study checked the safety of the Hexaxim vaccine in 713 infants aged 2 months and older in South Korea. Researchers tracked side effects like injection site reactions, fever, and crying after routine vaccination. The goal was to confirm the vaccine's safety in every…
Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:06 UTC
-
New combo vaccine for babies shows promise in large trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine called BK1310 in 370 healthy infants to see if it safely protects against several serious diseases: Hib, diphtheria, pertussis, tetanus, and polio. The vaccine was compared to existing vaccines. The goal was to check how well the infants' immune sy…
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:08 UTC
-
New combo vaccine shows promise in protecting infants from five serious diseases
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine called BK1310 in 267 healthy infants to see if it protects against tetanus, diphtheria, pertussis, polio, and bacterial meningitis as well as existing vaccines. Infants received three doses, and researchers measured their immune responses. The goal…
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:08 UTC
-
Booster shot study aims to keep teens safe from whooping cough
⭐️ VACCINE ⭐️ CompletedThis study tested a booster dose of the DTaP vaccine (BK1301) in 446 adolescents aged 11-12 who had already received the standard childhood series. The goal was to confirm the vaccine boosts immunity against diphtheria, tetanus, and pertussis (whooping cough) safely. Results show…
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:08 UTC
-
Nasal vaccine could shield newborns from whooping cough
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested a new whooping cough vaccine given as a nasal spray. 48 healthy adult men received either the vaccine or a placebo to check safety and immune response. The goal is to develop a single-dose vaccine that can protect infants from birth, before they get …
Phase: PHASE1 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:03 UTC
-
New nasal vaccine could stop whooping cough in its tracks
⭐️ VACCINE ⭐️ CompletedThis study tested a new whooping cough vaccine called BPZE1, given as a nasal spray, in healthy children aged 6 to 17. The goal was to see if it is safe and helps the body fight off whooping cough, either alone or with the standard shot vaccine Boostrix. About 368 children took p…
Phase: PHASE2 • Sponsor: ILiAD Biotechnologies • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:56 UTC
-
New 6-in-1 shot for babies shows promise in thai trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new combination vaccine called Shan6™, which protects against six diseases (diphtheria, tetanus, whooping cough, hepatitis B, Hib, and polio) in healthy infants and toddlers in Thailand. The trial involved 460 participants and compared Shan6™ to a similar 5-in…
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:51 UTC
-
Can a common antibiotic beat yaws? new trial puts linezolid to the test
Disease control CompletedThis phase 3 trial investigates whether the antibiotic linezolid can cure yaws, a bacterial skin infection that causes ulcers, as effectively as the standard treatment azithromycin. The study involves 384 children aged 5 to 18 with confirmed yaws. Participants receive either line…
Phase: PHASE3 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Which antibiotic works best for hidden anal chlamydia?
Disease control CompletedThis study compared two common antibiotics—azithromycin (single dose) and doxycycline (7-day course)—for treating anal chlamydia in women who also had a vaginal chlamydia infection. The goal was to see which treatment clears the anal infection better, since anal chlamydia often g…
Phase: PHASE4 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Simpler stomach bug treatment on the horizon?
Disease control CompletedThis study tested different combinations of the acid-blocker tegoprazan with antibiotics to treat H. pylori, a common stomach infection. 640 adults who had never been treated before received one of several drug regimens for 14 days. The goal was to see which combination worked be…
Phase: NA • Sponsor: Zhongshan Hospital (Xiamen), Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New stomach acid drug could boost h. pylori cure rates
Disease control CompletedThis completed study tested whether a new drug called keverprazan, combined with the antibiotic amoxicillin, can effectively treat a first-time H. pylori infection in adults. 264 participants took either keverprazan or esomeprazole (a standard acid reducer) plus amoxicillin for 1…
Phase: NA • Sponsor: Key Laboratory for Gastrointestinal Diseases of Gansu Province • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New Two-Drug combo shows promise against stomach bug
Disease control CompletedThis study tested a two-drug combination—tegoprazan (a stomach acid blocker) and amoxicillin (an antibiotic)—to treat H. pylori infection, a common stomach bug that can cause ulcers. The trial enrolled 50 adults who had not been treated for H. pylori before. The goal was to see i…
Sponsor: Soonchunhyang University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New antibiotic shows promise for scrub typhus fever
Disease control CompletedThis study tested whether the antibiotic tigecycline works better than the standard drug doxycycline for scrub typhus, a bacterial infection spread by mites. Thirty-one hospitalized patients were randomly assigned to receive either tigecycline or doxycycline. Researchers measured…
Phase: NA • Sponsor: Jin Soo Lee • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could a 3-Day antibiotic course beat the standard 7 days for chlamydia?
Disease control CompletedThis completed phase 4 trial tested whether taking doxycycline for 3 days works as well as the usual 7-day course for treating chlamydia. About 526 men and women with confirmed chlamydia took either a 3-day or 7-day regimen, with placebo pills used to keep the study blinded. Part…
Phase: PHASE4 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Antibiotic-Free future: study tests stopping trachoma treatment
Disease control CompletedThis study looked at whether it is safe to stop giving annual azithromycin to communities with low levels of trachoma, an eye infection that can cause blindness. Over 3,900 people in Niger took part. Researchers compared stopping treatment after at least 5 years versus continuing…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Cat scratch cure? injection may shrink swollen nodes faster
Disease control CompletedThis study tested whether injecting the antibiotic gentamicin directly into swollen lymph nodes helps people with cat scratch disease recover faster. 75 participants received either the injection or a placebo, along with standard oral antibiotics. The goal was to see if the injec…
Phase: PHASE3 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New antibiotic mix aims to tame tough stomach bug with fewer side effects
Disease control CompletedThis study tested different doses of the antibiotics minocycline and metronidazole, combined with bismuth and a stomach acid blocker, to treat Helicobacter pylori infections that didn't clear with previous treatments. 480 adults who had failed earlier therapy were randomly assign…
Phase: PHASE4 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Eye drop may prevent eyelash regrowth after trachoma surgery
Disease control CompletedThis study tested whether a steroid eye drop (fluorometholone) given for four weeks after trachoma surgery could stop eyelashes from growing back and rubbing against the eye. Over 2,400 people aged 15 and older took part. The goal was to see if this simple, low-cost addition to s…
Phase: PHASE3 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Stomach bug treatment may lower bleeding risk for heart patients
Disease control CompletedThis study looked at 121 people with heart disease who were getting a stent. Researchers checked if they also had a silent H. pylori stomach infection and whether treating that infection reduced stomach symptoms or bleeding. The goal was to see if eradicating the bug helps patien…
Phase: PHASE3 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New stomach bug treatment showdown: which works better?
Disease control CompletedThis study tested two different drug combinations to treat Helicobacter pylori, a stomach infection that can cause ulcers. About 400 adults took either a two-drug regimen (tegoprazan and amoxicillin) or a four-drug regimen (including bismuth and furazolidone). The goal was to see…
Phase: NA • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New dual therapy may simplify h. pylori treatment without losing effectiveness
Disease control CompletedThis study tested whether a two-drug combination (vonoprazan plus either amoxicillin or doxycycline) works as well as the standard four-drug bismuth quadruple therapy for eradicating H. pylori infection. 579 adults with H. pylori took one of three 14-day treatments. Researchers m…
Phase: NA • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New antibiotic shows promise for newborns with dangerous infections
Disease control CompletedThis study looked at how the antibiotic cefiderocol works in hospitalized infants under 3 months old with suspected or confirmed gram-negative bacterial infections. Researchers measured drug levels in the blood and checked for side effects in 30 babies. The goal was to find the r…
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New antibiotic shows promise for kids with tough infections
Disease control CompletedThis study tested the safety and how the body processes the antibiotic cefiderocol in hospitalized children aged 3 months to 18 years with serious bacterial infections. The goal was to see if the drug is safe and how it works in the body. 53 children participated, and the study i…
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New Two-Drug combo could simplify h. pylori treatment
Disease control CompletedThis study tested a 14-day treatment using two drugs (vonoprazan and amoxicillin) against a more complex seven-then-seven-day regimen for H. pylori infection in 337 adults in Taiwan. The goal was to see if the simpler dual therapy works just as well, with fewer side effects and e…
Phase: PHASE4 • Sponsor: Fu Jen Catholic University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Herbal combo boosts h. pylori treatment, study finds
Disease control CompletedThis study tested whether adding a traditional Chinese herbal formula (Banxiaxiexin decoction) to standard antibiotics can better treat H. pylori infection and related indigestion. 104 adults with both conditions took either the herbal combo or standard therapy for 14 days. The m…
Phase: PHASE3 • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a daily yogurt beat stomach bugs in kids?
Disease control CompletedThis study tested whether a yogurt containing LG21 probiotics can clear H. pylori infection in children aged 4-6. 140 kids were split into two groups: one ate the yogurt daily for 12 weeks, the other got no treatment. The main goal was to see if the yogurt could turn a positive s…
Phase: NA • Sponsor: Meiji China Investment Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New antibiotic shows promise for kids with tough infections
Disease control CompletedThis study tested a new antibiotic called MK-7655A in 115 children from birth to 18 years old who had serious bacterial infections. The goal was to see if the drug is safe and works better than standard treatments. Children were randomly assigned to receive either the new drug or…
Phase: PHASE2, PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New two-drug combo may beat standard four-drug therapy for stomach bug
Disease control CompletedThis study tested whether a simpler two-drug treatment (tegoprazan and amoxicillin) works better than the standard four-drug therapy for eradicating H. pylori, a bacteria that can cause stomach ulcers. 370 adults with H. pylori infection were randomly assigned to one of the two t…
Phase: PHASE4 • Sponsor: Zhang Xiaofeng,MD • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Laos study aims to wipe out stomach cancer by targeting common gut bug
Disease control CompletedThis completed study in Laos tested over 1,200 adults for H. pylori, a stomach bacteria linked to cancer. Those infected received a 14-day course of antibiotics and acid-reducing medication. The study also screened high-risk participants for early signs of stomach cancer. The goa…
Sponsor: Zero Helicobacter IGAN Network • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Shorter h. pylori treatment may work just as well as longer one
Disease control CompletedThis study looked at 508 adults with H. pylori infection to see if a 7-day triple therapy (vonoprazan, amoxicillin, tetracycline) works as well as a 14-day dual therapy (vonoprazan, amoxicillin). The goal was to compare how often the infection is cleared and how many side effects…
Sponsor: Yueyue Li • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Which works better for h. pylori? triple vs quadruple therapy showdown
Disease control CompletedThis study tested two different 14-day drug combinations to treat Helicobacter pylori, a bacteria that causes stomach inflammation and ulcers. Over 750 adults were randomly assigned to either a triple therapy (omeprazole, amoxicillin, clarithromycin) or a quadruple therapy (omepr…
Phase: PHASE4 • Sponsor: Azfar Farogh • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug combo aims to knock out stomach bug in phase 3 trial
Disease control CompletedThis study tested whether a new triple therapy containing DWP14012 is as good as the standard treatment for eradicating H. pylori, a bacteria that can cause stomach ulcers. 461 adults with confirmed H. pylori infection took part. The main goal was to see if the infection was gone…
Phase: PHASE3 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Rural patients get Hospital-Level care at home in landmark trial
Disease control CompletedThis study looked at whether giving hospital-level care to acutely ill adults in their own homes in rural areas works well. 160 people with various conditions like infections, heart failure, or COPD took part. The goal was to see if this approach could lower costs and help patien…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New whooping cough vaccine shows promise for toddlers
Disease control CompletedThis study tested a new booster vaccine called DTaPgen in 290 healthy toddlers aged 15 to 36 months. The goal was to see if it works as well as a currently licensed vaccine to protect against whooping cough, diphtheria, and tetanus. Children received a single shot, and researcher…
Phase: PHASE2, PHASE3 • Sponsor: BioNet-Asia Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Battle of the bacteria: which drug combo wins against resistant h. pylori?
Disease control CompletedThis study tested two different drug combinations in 782 people with H. pylori infection that was resistant to the antibiotic clarithromycin. One group received a triple therapy with a proton pump inhibitor, amoxicillin, and metronidazole, while the other received a quadruple the…
Phase: NA • Sponsor: Kangdong Sacred Heart Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New triple therapy may finally knock out tough stomach bug
Disease control CompletedThis study tested whether a three-drug combination containing rifabutin can wipe out Helicobacter pylori infections that didn't respond to earlier treatments. 360 adults who had failed prior therapy were randomly assigned to one of three regimens. The goal was to see which approa…
Phase: PHASE4 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 26, 2026 17:06 UTC
-
Stomach bug treatment may boost blood platelets in ITP patients
Disease control CompletedThis study looked at whether treating Helicobacter pylori (a common stomach infection) with antibiotics can raise platelet counts in people with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding and bruising. Researchers enrol…
Phase: NA • Sponsor: Al-Mustansiriyah University • Aim: Disease control
Last updated Jun 26, 2026 12:59 UTC
-
Rapid STI test aims to curb antibiotic misuse
Diagnosis CompletedThis study compares a new rapid point-of-care test for chlamydia, gonorrhea, and mycoplasma genitalium to standard lab testing. The goal is to see if the faster test helps doctors give the right antibiotics on the same day, reducing unnecessary or missed treatments. Participants …
Phase: NA • Sponsor: Hoffmann-La Roche • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
New rapid test for infection and inflammation put to the test
Diagnosis CompletedThis study looked at how well a new, quick finger-prick test (LumiraDx CRP) measures CRP levels compared to a standard lab test. CRP is a marker of infection, inflammation, or tissue injury. 79 adults with symptoms of these conditions took part. The goal was to see if the new tes…
Sponsor: LumiraDx UK Limited • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New test could speed up scrub typhus diagnosis
Diagnosis CompletedThis study tested a new molecular test (iiPCR) to diagnose scrub typhus, a bacterial infection spread by mites. Researchers compared the test's accuracy against standard methods in 345 participants in Thailand. The goal was to see if this tool could provide faster, reliable diagn…
Sponsor: University of Oxford • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
Which test is better for detecting h. pylori?
Diagnosis CompletedThis study compared two methods for diagnosing H. pylori infection: the rapid urease test (a simple, cheap test done during endoscopy) and a newer molecular test (PCR) that can also detect antibiotic resistance. Researchers enrolled 100 adults who needed an endoscopy. The goal wa…
Sponsor: Soonchunhyang University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Rapid HIV tests could end the epidemic by diagnosing in minutes
Diagnosis CompletedThis study tested three rapid, point-of-care HIV tests to see how well they work compared to standard lab tests. Researchers enrolled 224 adults at high risk for HIV in Baltimore. The goal was to see if faster results help more people start treatment or prevention the same day.
Phase: NA • Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Rapid dual test for HIV and syphilis could save newborns in guatemala
Diagnosis CompletedThis study tested a rapid fingerstick test that checks for both HIV and syphilis at the same time in pregnant women visiting prenatal clinics in Guatemala. The goal was to see if this quick, on-the-spot screening would lead to more women being diagnosed and treated during pregnan…
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
New rapid syphilis test put to the test in vancouver clinic
Diagnosis CompletedThis study checked how well a new rapid test (Reveal TP) detects syphilis compared to standard lab tests. About 600 adults visiting a Vancouver STI clinic took part. The goal was to see if the quick finger-prick test is accurate enough for routine use.
Phase: NA • Sponsor: MedMira Laboratories Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 08:14 UTC
-
New PET scan technique aims to sniff out hidden infections
Diagnosis CompletedThis early study tested whether a special PET scan using a radioactive form of vitamin B9 (11C-PABA) can help doctors see infections deep inside the body. Researchers scanned 13 healthy people and patients with known or suspected infections. The goal was to see if this method can…
Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
Emergency room study aims to catch more STIs in teens
Diagnosis CompletedThis study looked at better ways to screen teenagers (ages 15-21) for chlamydia and gonorrhea when they visit emergency departments. Researchers compared offering STI tests to everyone versus only to those with certain risk factors. The goal was to find the most effective and cos…
Phase: NA • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
New rapid tests aim to stop STIs in their tracks for pregnant women in zimbabwe
Diagnosis CompletedThis study tested a strategy of using rapid, point-of-care diagnostic tests for sexually transmitted infections (STIs) in pregnant women attending antenatal clinics in Zimbabwe. Over 1,000 women were offered testing for chlamydia, gonorrhea, trichomoniasis, syphilis, and hepatiti…
Phase: NA • Sponsor: London School of Hygiene and Tropical Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
Hospital push could shield seniors from preventable diseases
Prevention CompletedThis trial evaluates whether a hospital-based remedial vaccination strategy can improve Tdap-IPV (tetanus, diphtheria, pertussis, polio) vaccination rates in adults aged 65 and older in the Sarthe region of France. Participants are randomly assigned to receive either the remedial…
Phase: NA • Sponsor: Centre Hospitalier le Mans • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
New study tests whooping cough vaccine in pregnant women with HIV
Prevention CompletedThis study looked at how well the whooping cough (pertussis) vaccine works in pregnant women with and without HIV, and whether it is safe for them and their babies. Over 500 pregnant women received the vaccine during their second or third trimester. Researchers measured antibody …
Phase: PHASE4 • Sponsor: Farzanah Laher • Aim: Prevention
Last updated Jun 27, 2026 12:34 UTC
-
Van clinic delivers lifesaving prevention to women at high risk
Prevention CompletedThis study tested a pop-up clinic inside a van for women who inject drugs and exchange sex in north Seattle. The goal was to see if offering HIV prevention pills, addiction medications, and quick STI testing in a convenient location would help more women start and stay on these t…
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 27, 2026 09:07 UTC
-
Phone-Based support could lower HIV and alcohol harm
Prevention CompletedThis study tested a mobile program called Comunică to help Romanian gay and bisexual men reduce HIV risk and heavy drinking. 300 participants used their phones or laptops to complete surveys and eight one-hour sessions with a counselor or by reading health information. The progra…
Phase: NA • Sponsor: Columbia University • Aim: Prevention
Last updated Jun 26, 2026 17:15 UTC
-
Probiotic shows promise in easing antibiotic side effects in kids
Symptom relief CompletedThis study tested whether a probiotic called Bifidobacterium breve PRL2020 could reduce stomach issues like diarrhea in 121 children aged 3-12 who were taking amoxicillin antibiotics. The children took the probiotic alongside their antibiotic treatment. The goal was to see if it …
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Study links NSAIDs to severe bacterial infections
Knowledge-focused CompletedThis study looked at 335 adults hospitalized with bacterial infections to see if taking NSAIDs (like ibuprofen) before admission made their infections more severe. Researchers compared those with complicated infections (abscesses, needing surgery) to those with simpler infections…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Scientists create controlled whooping cough infection to speed up vaccine research
Knowledge-focused CompletedThis completed phase 1 study tested whether giving healthy adults a controlled dose of whooping cough bacteria via nasal spray can safely cause mild infection. The goal was to establish a human infection model for future vaccine and treatment research. 79 participants aged 18-40 …
Phase: PHASE1 • Sponsor: Dalhousie University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Stomach bug tied to belly fat and blood sugar issues?
Knowledge-focused CompletedThis study looked at health records from over 5,000 adults to see if having an H. pylori stomach infection is linked to metabolic syndrome—a cluster of conditions like high blood sugar, high blood pressure, and excess belly fat. Researchers compared people with and without the in…
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Meth reduction may lower STI risk, small study suggests
Knowledge-focused CompletedThis completed study looked at 59 men who have sex with men and use methamphetamine. Researchers used a program that gives rewards for drug-free urine samples to help them cut back. They measured inflammation in the rectum and tracked STI/HIV risk behaviors over 8 weeks. The goal…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Massive ethiopian trial tests hygiene vs. antibiotics for blinding eye disease
Knowledge-focused CompletedThis large study in rural Ethiopia looked at whether providing clean water, sanitation, and face-washing education can reduce trachoma infections in communities that have already received many rounds of antibiotics. Over 47,000 people from 40 communities took part. The goal is to…
Phase: PHASE3 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Massive german study reveals hidden toll of chlamydia infections
Knowledge-focused CompletedThis study looked at health insurance records of over 81,000 people aged 14 to 44 in Germany to see how often chlamydia leads to serious health problems like infertility or pelvic disease, and how much it costs the healthcare system. Researchers tracked infections, complications,…
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Nanjing study reveals h. pylori resistance trends in thousands of patients
Knowledge-focused CompletedThis study looked at 7,227 patients in Nanjing to understand how resistant the H. pylori bacteria is to common antibiotics. The goal was to find out which antibiotics still work best and to help doctors choose the right treatment for each patient. No new treatments were tested; i…
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Scientists seek perfect antibiotic dose for young burn victims
Knowledge-focused CompletedThis study aimed to find the best dose of the antibiotic ceftazidime for critically ill children with severe burns. Researchers took blood samples from 3 children to measure how the drug moves through the body. The goal was to learn how to personalize dosing to improve treatment …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
ICU antibiotic study reveals resistance risks
Knowledge-focused CompletedThis study examined whether giving ICU patients the same antibiotic they had before, versus a different one, affects the development of drug-resistant bacteria. Researchers looked at 197 adults with Gram-negative infections. The goal was to understand how antibiotic choice impact…
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Scientists map gut bugs in double infection
Knowledge-focused CompletedThis study looked at 42 adults with both H. pylori infection and small intestinal bacterial overgrowth (SIBO). Researchers used advanced DNA and chemical tests on stool samples to map the types of gut bacteria and their byproducts. The goal was to better understand how these two …
Sponsor: Zhongshan Hospital (Xiamen), Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
AI model aims to predict ICU deaths from superbug blood infections
Knowledge-focused CompletedThis study looked at 197 ICU patients with bloodstream infections caused by carbapenem-resistant bacteria (superbugs). Researchers used machine learning to analyze patient data and predict which patients were at higher risk of dying. The goal is to create a tool that helps doctor…
Sponsor: Kocaeli University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Scientists map h. Pylori's resistance to antibiotics
Knowledge-focused CompletedThis study looked at 100 adults with H. pylori infection to find out which antibiotics the bacteria are resistant to and which harmful genes they carry. Researchers took stomach biopsies during endoscopy to test the bacteria and also asked about diet and medication use. The goal …
Phase: NA • Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New antibiotic studied in kids: first step toward better infection treatment
Knowledge-focused CompletedThis early-phase study tested a single dose of the antibiotic omadacycline (Nuzyra) in 23 children aged 8 to 17 who were hospitalized with bacterial infections. Researchers measured how the drug moved through the body and checked for side effects. The goal was to gather safety an…
Phase: PHASE1 • Sponsor: Paratek Pharmaceuticals Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Stomach bug treatment may alter vaginal health, study finds
Knowledge-focused CompletedThis study looked at whether antibiotics for H. pylori (a stomach infection) change the natural bacteria in the vagina. Researchers followed 73 women getting treatment and 10 healthy women. They collected vaginal samples before and after treatment to see if the bacteria mix shift…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Whooping cough vaccine safety under the microscope in thailand
Knowledge-focused CompletedThis completed study looked at the safety of the VacPertagen whooping cough vaccine in over 5,400 people in Thailand, including pregnant women and their newborns. Healthcare workers reported any side effects after vaccination using standard forms. The goal was to catch any unexpe…
Sponsor: BioNet-Asia Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
3000 patients studied to see Real-World success of h. pylori treatment
Knowledge-focused CompletedThis study looked back at medical records of 3000 people treated for H. pylori infection to see how often treatment actually works outside of controlled trials. Researchers collected data on which treatments were used and what factors, like antibiotic resistance or patient habits…
Sponsor: Run-hua Li • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New imaging method could spot hidden bacteria
Knowledge-focused CompletedThis study tested a new imaging technique using a radioactive tracer called 11C-trimethoprim to see how it spreads in the bodies of 16 adults with suspected bacterial infections. Participants had PET/CT scans to track the tracer over time. The goal was to learn how the tracer beh…
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Whooping cough vaccine in pregnancy: new study looks at how antibodies pass to babies
Knowledge-focused CompletedThis completed study looked at 200 women and their infants to understand how the whooping cough vaccine given during pregnancy affects the baby's immune protection. Researchers measured antibody levels in mothers and in umbilical cord blood at birth, as well as in infants after t…
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire Saint Pierre • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Speedy bug ID: new tests aim to cut antibiotic guesswork in ICU blood infections
Knowledge-focused CompletedThis study tested whether three new diagnostic tools could help doctors pick the best antibiotic faster for ICU patients with Gram-negative bloodstream infections. Researchers compared standard lab methods to the new tests in 100 patients. The goal was to see if more patients got…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
New antibiotic TQD3524 tested in kidney patients
Knowledge-focused CompletedThis early-stage study tested a single dose of the antibiotic TQD3524 in 48 people with varying degrees of kidney function. The goal was to see how the drug moves through the body and is removed, especially by the kidneys, and to check for any safety issues. The study did not aim…
Phase: PHASE1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
New drug interaction study completed in healthy and infected volunteers
Knowledge-focused CompletedThis study looked at how a new drug called linaprazan glurate interacts with common antibiotics (clarithromycin, amoxicillin) and bismuth in 56 adults. Some participants were healthy and H. pylori-negative, while others had H. pylori infection. The goal was to measure drug levels…
Phase: PHASE1 • Sponsor: Jiangsu Sinorda Biomedicine Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Could a common stomach bug raise your heart disease risk?
Knowledge-focused CompletedThis study looked at 300 people to see if a common stomach infection, H. pylori, is linked to unhealthy blood fat levels that can lead to heart disease. Researchers measured triglycerides and 'good' cholesterol to calculate a heart risk score. The goal is to understand if treatin…
Sponsor: Tanta University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Gene clue to Kids' stomach bugs revealed
Knowledge-focused CompletedThis study looked at whether a specific gene (TLR9) influences how children's bodies react to H. pylori, a bacteria that can cause stomach pain and inflammation. Researchers compared 50 infected children with 50 uninfected children, all aged 1 to 18, using endoscopy and genetic t…
Phase: NA • Sponsor: Benha University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Generic vonoprazan put to the test against Brand-Name voquezna
Knowledge-focused CompletedThis study compared a generic vonoprazan 20 mg tablet to the brand-name Voquezna in 28 healthy adults. Participants took a single dose of each under fasting conditions to see if the generic releases the same amount of drug into the bloodstream. The goal was to check bioequivalenc…
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
ICU antibiotic dosing: what really matters?
Knowledge-focused CompletedThis study looked at 156 critically ill patients to find out what factors help achieve the right levels of beta-lactam antibiotics in the blood. Researchers collected clinical data and used therapeutic drug monitoring to see which patients reached target concentrations. The goal …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Paying it forward boosts STI testing in chinese men
Knowledge-focused CompletedThis study tested whether a pay-it-forward approach—where one person's donation covers testing for the next person—could increase gonorrhea and chlamydia testing among men in China. Over 1,200 men who had sex in the past year but hadn't been tested recently took part. The goal wa…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Mass screening in bhutan aims to stop stomach cancer before it starts
Knowledge-focused CompletedThis study tested over 1,000 people in Bhutan for H. pylori, a stomach infection that can lead to stomach cancer. Researchers measured infection rates and stomach damage to understand the problem and plan a national prevention program. Participants were from rural villages, and t…
Phase: NA • Sponsor: Zero Helicobacter IGAN Network • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Wearable pump trial aims to free hospital patients from IV stands
Knowledge-focused CompletedThis study tested special wearable pumps (elastomeric pumps) to give antibiotics through a drip to hospital patients. Nine adults with bacterial infections took part to see if the pumps are safe, easy to use, and could save time and money compared to traditional methods. The goal…
Phase: NA • Sponsor: Stuart Bond • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Study links vaginal germs to preterm birth risk
Knowledge-focused CompletedThis study followed 603 pregnant women in South Africa to see if infections or bacteria in the vagina are linked to how early they give birth. Researchers tested for sexually transmitted infections, yeast, and other germs at the start of pregnancy and again at 30-34 weeks. The go…
Sponsor: University of Bern • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:35 UTC
-
Bismuth combo therapy for stomach bug under review
Knowledge-focused CompletedThis study looked back at medical records of 1,730 adults with H. pylori infection who received bismuth-containing quadruple therapy as their first treatment. Researchers compared how well different drug combinations worked and what side effects occurred. The goal was to identify…
Sponsor: Yueyue Li • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:22 UTC